Skip to Main Content

Paper Details

A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies.
Clin Cancer Res
25
2021
Author NameAffiliation
Jordi RodonThe University of Texas MD Anderson Cancer Center
Shubham PantThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2